CGM and DFU Healing Post-discharge
NCT: NCT06054659 · COMPLETED
Brief Summary
The purpose of this study is to look at the benefits of using a Continuous Glucose Monitoring (CGM) system compared with standard-of-care testing for patients with type 2 diabetes and diabetic foot ulcers (DFU) and how this will improve wound healing. The CGM system allows medical staff and patients with diabetes to monitor and make treatment decisions to improve glucose control, without the need for performing fingersticks. Hence, the use of CGM will decrease the painful and burdensome task of performing finger sticks several times per day and may prevent low blood glucose in patients with diabetes.
Frequently Asked Questions
What is CGM and DFU Healing Post-discharge?
CGM and DFU Healing Post-discharge is a clinical trial registered under NCT06054659. Current status: COMPLETED.
What is the status of NCT06054659?
The current status of NCT06054659 (CGM and DFU Healing Post-discharge) is: COMPLETED.
When did CGM and DFU Healing Post-discharge start?
CGM and DFU Healing Post-discharge started on 2024-02-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.